Lv2
140 积分 2024-01-22 加入
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
3天前
已完结
Allogeneic bone marrow–derived mesenchymal stromal cells for hepatitis B virus–related acute‐on‐chronic liver failure: A randomized controlled trial
16天前
已完结
Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
29天前
已完结
Identification, structure, and agonist design of an androgen membrane receptor
1个月前
已完结
Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer
1个月前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
1个月前
已完结
BTK inhibitors: past, present, and future
1个月前
已完结
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
1个月前
已完结
An Antibody‐Drug Conjugate for Multiple Myeloma Prepared by Multi‐Arm Linkers
1个月前
已完结
Abstract 2700: ORM-6151: A first-in-class CD33-antibody enabled GSPT1 degrader for AML
1个月前
已关闭
皖公网安备34019202002308
